(Q37760887)

22 August 2017

title

Inflammatory breast cancer--The Royal Marsden Hospital experience: a review of 155 patients treated from 1990 to 2007. (English)

1 reference

22 August 2017

0 references

Stephanie Sutherland

1

1 reference

22 August 2017

Sue Ashley

2

1 reference

22 August 2017

Geraldine Walsh

3

1 reference

22 August 2017

Ian E Smith

4

1 reference

22 August 2017

Stephen R D Johnston

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 June 2010

1 reference

22 August 2017

1 reference

22 August 2017

volume

116

1 reference

22 August 2017

issue

11 Suppl

1 reference

22 August 2017

page(s)

2815-2820

1 reference

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Defining the clinical diagnosis of inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Inflammatory carcinomas of the breast: A clinical, pathological, or a clinical and pathological definition?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Paclitaxel in the multimodality treatment for inflammatory breast carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Trends for Inflammatory Breast Cancer: Is Survival Improving?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Paclitaxel improves the prognosis in estrogen receptor negative inflammatory breast cancer: the M. D. Anderson Cancer Center experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Prognostic significance of HER-2 status in women with inflammatory breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25178

7 January 2021

Identifiers

DOI

10.1002/CNCR.25178

1 reference

22 August 2017

1 reference